{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:23:53Z","timestamp":1761899033566,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cancergen.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T19:59:36Z","timestamp":1529783976000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer"],"prefix":"10.1016","volume":"228-229","author":[{"given":"Ver\u00f3nica","family":"Castillo-Guardiola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-7684","authenticated-orcid":false,"given":"M Desamparados","family":"Sarabia-Meseguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Mar\u00edn-Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"S\u00e1nchez-Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-2096","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Alonso-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Noguera-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ruiz-Espejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2018.06.002_bib0001","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.7314\/APJCP.2015.16.6.2177","article-title":"The spectrum of genetic mutations in breast cancer","volume":"16","author":"Sheikh","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0002","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.30498","article-title":"A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes","volume":"123","author":"Buys","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0003","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3949\/ccjm.83a.14057","article-title":"Managing patients at genetic risk of breast cancer","volume":"83","author":"Pederson","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0004","doi-asserted-by":"crossref","first-page":"e55681","DOI":"10.1371\/journal.pone.0055681","article-title":"Whole exome sequencing suggests much of non-BRCA1\/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles","volume":"8","author":"Gracia-Aznarez","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0005","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","article-title":"SEOM clinical guidelines in hereditary breast and ovarian cancer","volume":"17","author":"Llort","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0011","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0036-1579759","article-title":"Li-Fraumeni syndrome","volume":"5","author":"Correa","year":"2016","journal-title":"J Pediatr Genet"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0013","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","article-title":"Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer","volume":"295","author":"Walsh","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0014","first-page":"6643","article-title":"Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype","volume":"63","author":"Olivier","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN Guidelines insights: genetic\/familial high-risk assessment: breast and ovarian","volume":"15","author":"Daly","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0017","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Cast\u00e9ra","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cancergen.2018.06.002_bib0018","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmg.2008.058958","article-title":"High frequency of de novo mutations in Li\u2013Fraumeni syndrome","volume":"46","author":"Gonzalez","year":"2009","journal-title":"J Med Genetics"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217304507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217304507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:42:23Z","timestamp":1761896543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217304507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":12,"alternative-id":["S2210776217304507"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.06.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}